Cargando…

Glutaminase inhibition in multiple myeloma induces apoptosis via MYC degradation

Multiple Myeloma (MM) is an incurable hematological malignancy affecting millions of people worldwide. As in all tumor cells both glucose and more recently glutamine have been identified as important for MM cellular metabolism, however there is some dispute as to the role of glutamine in MM cell sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Effenberger, Madlen, Bommert, Kathryn S., Kunz, Viktoria, Kruk, Jessica, Leich, Ellen, Rudelius, Martina, Bargou, Ralf, Bommert, Kurt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689652/ https://www.ncbi.nlm.nih.gov/pubmed/29156762 http://dx.doi.org/10.18632/oncotarget.20691

Ejemplares similares

Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models
por: Kunz, Viktoria, et al.
Publicado: (2020)

Eosinophils and Megakaryocytes Support the Early Growth of Murine MOPC315 Myeloma Cells in Their Bone Marrow Niches
por: Wong, David, et al.
Publicado: (2014)

Novel molecular subgroups within the context of receptor tyrosine kinase and adhesion signalling in multiple myeloma
por: Leich, Ellen, et al.
Publicado: (2021)

Prognostic value of extracellular matrix gene mutations and expression in multiple myeloma
por: Evers, Marietheres, et al.
Publicado: (2023)

A Multicriteria Approach to Find Predictive and Sparse Models with Stable Feature Selection for High-Dimensional Data
por: Bommert, Andrea, et al.
Publicado: (2017)

Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2
por: Xiao, Daibiao, et al.
Publicado: (2015)

Rare SNPs in receptor tyrosine kinases are negative outcome predictors in multiple myeloma
por: Keppler, Sarah, et al.
Publicado: (2016)

Benchmark of filter methods for feature selection in high-dimensional gene expression survival data
por: Bommert, Andrea, et al.
Publicado: (2021)

A Novel Mouse Model for Multiple Myeloma (MOPC315.BM) That Allows Noninvasive Spatiotemporal Detection of Osteolytic Disease
por: Hofgaard, Peter O., et al.
Publicado: (2012)

c-Myc suppression of miR-23 enhances mitochondrial glutaminase and glutamine metabolism
por: Gao, Ping, et al.
Publicado: (2009)

Glutaminase inhibitor CB-839 synergizes with carfilzomib in resistant multiple myeloma cells
por: Thompson, Ravyn M., et al.
Publicado: (2017)

Cynaropicrin disrupts tubulin and c-Myc-related signaling and induces parthanatos-type cell death in multiple myeloma
por: Boulos, Joelle C., et al.
Publicado: (2023)

c-FLIP Mediates Resistance of Hodgkin/Reed-Sternberg Cells to Death Receptor–induced Apoptosis
por: Mathas, Stephan, et al.
Publicado: (2004)

Tuning the Fröhlich exciton-phonon scattering in monolayer MoS(2)
por: Miller, Bastian, et al.
Publicado: (2019)

RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS
por: Seibold, Marcel, et al.
Publicado: (2019)

Efficient Transient Transfection of Human Multiple Myeloma Cells by Electroporation – An Appraisal
por: Steinbrunn, Torsten, et al.
Publicado: (2014)

The OTUD6B‐LIN28B‐MYC axis determines the proliferative state in multiple myeloma
por: Paulmann, Carmen, et al.
Publicado: (2022)

Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015)

Targeting glutaminase1 and synergizing with clinical drugs achieved more promising antitumor activity on multiple myeloma
por: Qiu, Qiang, et al.
Publicado: (2019)

Exon-4 Mutations in KRAS Affect MEK/ERK and PI3K/AKT Signaling in Human Multiple Myeloma Cell Lines
por: Weißbach, Susann, et al.
Publicado: (2020)

Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
por: Leich, E, et al.
Publicado: (2013)

MYC inhibitors in multiple myeloma
por: Martínez-Martín, Sandra, et al.
Publicado: (2021)

The direct Myc target Pim3 cooperates with other Pim kinases in supporting viability of Myc-induced B-cell lymphomas
por: Forshell, Linus Plym, et al.
Publicado: (2011)

The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016)

Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019)

Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)

Q-ing tumor glutaminase therapy
por: Stine, Zachary E., et al.
Publicado: (2015)

Governing glutaminolysis by regulation of glutaminase succinylation
por: Ma, Qingxia, et al.
Publicado: (2021)

The Role of Glutamine and Glutaminase in Pulmonary Hypertension
por: Wang, Shang, et al.
Publicado: (2022)

Targeting glutaminase to starve lymphoma cells
por: Dumontet, Charles
Publicado: (2022)

Gamabufotalin triggers c-Myc degradation via induction of WWP2 in multiple myeloma cells
por: Yu, Zhenlong, et al.
Publicado: (2016)

Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
por: Rudelius, Martina, et al.
Publicado: (2018)

MYC amplifications in myeloma cell lines: correlation with MYC-inhibitor efficacy
por: Holien, Toril, et al.
Publicado: (2015)

MYC dysregulation in the progression of multiple myeloma
por: Misund, K, et al.
Publicado: (2019)

Anaplastic multiple myeloma with MYC rearrangement
por: Ichikawa, Satoshi, et al.
Publicado: (2021)

Ancistrocladinium A Induces Apoptosis in Proteasome Inhibitor-Resistant Multiple Myeloma Cells: A Promising Therapeutic Agent Candidate
por: Brünnert, Daniela, et al.
Publicado: (2023)

Metabolic modulation of neurogenesis: Role of glutaminase-2
por: Salomoni, Paolo
Publicado: (2014)

Targeting hepatic glutaminase activity to ameliorate hyperglycemia
por: Miller, Russell A., et al.
Publicado: (2018)

Safety assessment of glutaminase from Aspergillus niger
por: Vo, Trung Duc, et al.
Publicado: (2020)

Glutaminase inhibition in renal cell carcinoma therapy
por: Raczka, Aleksandra M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_6fhu85ln6e915vplthoioug83m